
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Schizochytrium is a marine microalgae that provides concentrated docosahexaenoic acid (DHA), an omega-3 fatty acid comprising up to 40% of its lipid content. DHA enhances neuronal membrane fluidity and supports cardiovascular health through anti-inflammatory eicosanoid production.

Reported Benefits (Provisional)
Origin & History

Schizochytrium is a microalga cultivated for its high DHA (docosahexaenoic acid) content. It is grown in controlled environments and harvested for its oil, which is extracted through a process of fermentation and purification.
Research Narrative (Provisional)
Schizochytrium has been studied in human trials for its effects on cardiovascular and cognitive health. Evidence supports its role in improving lipid profiles and supporting brain function.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in DHA, an omega-3 fatty acid essential for brain health. - Contains other essential fatty acids and antioxidants. - Provides vitamins and minerals essential for overall health.
Reported Mechanism (Provisional)
DHA from Schizochytrium integrates into neuronal phospholipid membranes, particularly phosphatidylserine and phosphatidylethanolamine, enhancing membrane fluidity and synaptic transmission. It serves as a precursor to specialized pro-resolving mediators like resolvins and protectins, which modulate inflammatory responses. DHA also activates PPAR-α receptors, promoting fatty acid oxidation and reducing triglyceride synthesis.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 100-500 participants demonstrate that algal DHA supplementation (200-2000mg daily) significantly improves cognitive performance and memory in both healthy adults and those with mild cognitive decline. Cardiovascular studies show 10-20% reductions in triglycerides and modest improvements in blood pressure after 8-12 weeks of supplementation. Meta-analyses confirm algal DHA produces equivalent benefits to fish-derived omega-3s, with high-quality evidence supporting both neurological and cardiovascular outcomes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







